~~<i id='E5A444E07B'><strike id='E5A444E07B'><tt id='E5A444E07B'><pre id='E5A444E07B'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：explore 2025-09-30 10:09:22 Page View：865

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Physician assistants need a new name. Here's what it should be
Next article： In Memoriam: Notable people who died in 2023

explore

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

2:04UkrainianmilitaryservicemanIgorOvcharruckholdsadefusedclusterbombfromanMSLRmissile,amongadisplay

As demand for Covid shots wanes, Moderna seeks its next success

RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

Fauci's latest grilling in Congress: 9 hours, behind closed doors

AnthonyFaucispentninehoursonCapitolHillyesterday,talkingCovidbehindcloseddoors—andthatwasjustdayone.

WSS

explore

explore

knowledge

explore

Fauci's latest grilling in Congress: 9 hours, behind closed doors